While three-quarters (76 per cent) of U.S. employers say they provide coverage of glucagon-like peptide-1 drugs for diabetes management, about a quarter (27 per cent) provide coverage of these drugs for weight loss, according to a new survey by the International Foundation of Employee Benefit Plans. The survey, which polled more than 200 U.S. benefits […]
As the proportion of Canadians living with one or more chronic disease continues to rise, plan sponsors have the opportunity to provide specific solutions to some of the most common conditions in their employee population, said Karen Callaghan, senior director of chronic disease education and patient support at Novo Nordisk, during Benefits Canada‘s 2023 Healthy […]
“We’re now in a very exciting time where we have treatments with previously unseen capacity to improve the control of type 2 diabetes and help our patients manage weight,” said Dr. Sue Pedersen, a specialist in endocrinology and metabolism from Calgary, during a webinar hosted by Benefits Canada and sponsored by Eli Lilly Canada in […]
In 2022, some of the top chronic conditions affecting group benefits plans were diabetes, obesity, depression and arthritis. Diabetes was the No. 1 ranked condition for drug claims in 2022, knocking rheumatoid arthritis down to the No. 2 spot, according to Telus Health’s annual drug plan trends report. And the 2023 Benefits Canada Healthcare Survey […]
The average cost of employer-sponsored health benefits in Canada is expected to decline to five per cent in 2024, down from 7.5 per cent in 2023, according to a report by Aon. The report, which is based on insights from more than 100 global Aon offices that broker, administer or advise on employer-sponsored medical plans, found […]
More than 5,600 Ford of Canada workers have voted in favour of ratifying a three-year collective agreement that includes improvements to the defined contribution and defined benefit pension plans. The agreement “fundamentally transforms pension plans,” said Lana Payne, Unifor national president, in a press release. Under the agreement, the DB plan’s basic monthly benefit rate […]
More than half (54 per cent) of Canadian benefits plan members currently live with at least one diagnosed chronic health condition, according to the 2023 Benefits Canada Healthcare Survey. It found the top current diagnoses were a mental-health condition such as depression or anxiety (18 per cent), high cholesterol (12 per cent), arthritis (12 per […]
In 2022, Xero sent out a global survey to all of its employees asking them to rank the most important components of its total rewards program, from time off to flexible working policies, salaries to employee benefits. The software company’s Canadian employees ranked health benefits as one of the most important aspects of total rewards. […]
Canadian plan sponsors and insurers are revisiting how they classify obesity drugs under their benefits plans, amid plan members’ rising demand for Ozempic as a weight-loss treatment. Ozempic, also known under the generic name semaglutide, is a drug used to treat type 2 diabetes. However, the medication has also been credited as a weight-loss treatment, […]
Three main drug categories — diabetes, asthma and stimulants for attention deficit hyperactivity disorder — accounted for rising drug claims in 2022, according to Lavina Viegas, Telus Health’s director of client account management, speaking during Benefits Canada‘s 2023 Benefits & Pension Summit in June. Referring to Telus Health’s 2023 drug plan trends report, she said […]